Cambiar Investors LLC Purchases 6,350 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Cambiar Investors LLC lifted its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 31.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,655 shares of the company's stock after purchasing an additional 6,350 shares during the period. Cambiar Investors LLC owned about 0.18% of U.S. Physical Therapy worth $2,256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Canada Pension Plan Investment Board bought a new position in shares of U.S. Physical Therapy in the second quarter worth about $28,000. Innealta Capital LLC purchased a new position in U.S. Physical Therapy in the 2nd quarter worth approximately $30,000. Quest Partners LLC boosted its stake in U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company's stock worth $32,000 after purchasing an additional 337 shares during the period. Quarry LP grew its holdings in U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after buying an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC purchased a new stake in U.S. Physical Therapy during the 2nd quarter valued at approximately $51,000.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Bank of America restated a "neutral" rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st. Finally, Barrington Research reiterated an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th.

U.S. Physical Therapy Price Performance

USPH traded up $1.20 during trading hours on Friday, hitting $81.38. The company's stock had a trading volume of 146,319 shares, compared to its average volume of 102,509. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of 76.77, a P/E/G ratio of 3.81 and a beta of 1.38. The business's 50-day moving average price is $82.97 and its 200-day moving average price is $91.81. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same quarter last year, the firm earned $0.76 earnings per share. The business's quarterly revenue was up 10.4% on a year-over-year basis. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were paid a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 2.16%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy's payout ratio is 166.04%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company's stock, valued at $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of the business's stock in a transaction dated Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the purchase, the director now owns 18,904 shares in the company, valued at $1,627,445.36. This represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.70% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.